IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 116 filers reported holding IVERIC BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,430,894 | +56.2% | 223,218 | +37.4% | 0.01% | +75.0% |
| Q4 2022 | $3,477,369 | +43.2% | 162,418 | +15.7% | 0.00% | +33.3% |
| Q3 2022 | $2,429,000 | +66.3% | 140,426 | -7.5% | 0.00% | +50.0% |
| Q2 2022 | $1,461,000 | -57.8% | 151,855 | -26.1% | 0.00% | -33.3% |
| Q1 2022 | $3,460,000 | -4.9% | 205,580 | -5.6% | 0.00% | 0.0% |
| Q4 2021 | $3,640,000 | +3.0% | 217,680 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $3,535,000 | +109.2% | 217,680 | +11.1% | 0.00% | +100.0% |
| Q2 2021 | $1,690,000 | +75.7% | 195,882 | +25.9% | 0.00% | +100.0% |
| Q1 2021 | $962,000 | +16.7% | 155,632 | +30.6% | 0.00% | 0.0% |
| Q4 2020 | $824,000 | +22.6% | 119,177 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $672,000 | +5.0% | 119,177 | -5.0% | 0.00% | 0.0% |
| Q2 2020 | $640,000 | – | 125,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
| Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
| Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
| COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
| Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
| ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
| Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
| Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
| Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
| Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |